120 related articles for article (PubMed ID: 11497265)
1. 9-Nitrocamptothecin is an effective drug for the treatment of human lung tumors: comparison of in vitro and in vivo studies.
Han Z; Wyche JH; Sands H; Pantazis P
Anticancer Res; 2001; 21(3B):1823-7. PubMed ID: 11497265
[TBL] [Abstract][Full Text] [Related]
2. Establishment of human prostate tumor xenografts in nude mice and response to 9-nitrocamptothecin in vivo and in vitro does not correlate with the expression of various apoptosis-regulating proteins.
Pantazis P; Chatterjee D; Wyche J; DeJesus A; Early J; Plaschke S; Giovanella B
J Exp Ther Oncol; 1996 Sep; 1(5):322-33. PubMed ID: 9414421
[TBL] [Abstract][Full Text] [Related]
3. Regression of human breast carcinoma tumors in immunodeficient mice treated with 9-nitrocamptothecin: differential response of nontumorigenic and tumorigenic human breast cells in vitro.
Pantazis P; Early JA; Kozielski AJ; Mendoza JT; Hinz HR; Giovanella BC
Cancer Res; 1993 Apr; 53(7):1577-82. PubMed ID: 8453626
[TBL] [Abstract][Full Text] [Related]
4. Zoledronic acid is unable to induce apoptosis, but slows tumor growth and prolongs survival for non-small-cell lung cancers.
Li YY; Chang JW; Chou WC; Liaw CC; Wang HM; Huang JS; Wang CH; Yeh KY
Lung Cancer; 2008 Feb; 59(2):180-91. PubMed ID: 17900752
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship of alkyl 9-nitrocamptothecin esters.
Cao ZS; Pantazis P; Mendoza J; Early J; Kozielski A; Harris N; Giovanella B
Acta Pharmacol Sin; 2003 Feb; 24(2):109-19. PubMed ID: 12546717
[TBL] [Abstract][Full Text] [Related]
6. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cł.
Malkinson AM; Siegel D; Forrest GL; Gazdar AF; Oie HK; Chan DC; Bunn PA; Mabry M; Dykes DJ; Harrison SD
Cancer Res; 1992 Sep; 52(17):4752-7. PubMed ID: 1324793
[TBL] [Abstract][Full Text] [Related]
7. Silibinin induces growth inhibition and apoptotic cell death in human lung carcinoma cells.
Sharma G; Singh RP; Chan DC; Agarwal R
Anticancer Res; 2003; 23(3B):2649-55. PubMed ID: 12894553
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic efficacy of 9-nitrocamptothecin in the treatment of human malignant melanoma cells in vitro.
Pantazis P; Early JA; Mendoza JT; DeJesus AR; Giovanella BC
Cancer Res; 1994 Feb; 54(3):771-6. PubMed ID: 8306340
[TBL] [Abstract][Full Text] [Related]
9. Retinoblastoma tumor suppressor gene expression determines the response to sequential flavopiridol and doxorubicin treatment in small-cell lung carcinoma.
Budak-Alpdogan T; Chen B; Warrier A; Medina DJ; Moore D; Bertino JR
Clin Cancer Res; 2009 Feb; 15(4):1232-40. PubMed ID: 19174488
[TBL] [Abstract][Full Text] [Related]
10. Chemosensitivity of human small cell carcinoma of the lung detected by flow cytometric DNA analysis of drug-induced cell cycle perturbations in vitro.
Engelholm SA; Spang-Thomsen M; Vindeløv LL; Brünner NA
Cytometry; 1986 May; 7(3):243-50. PubMed ID: 3011370
[TBL] [Abstract][Full Text] [Related]
11. Site-specific chemosensitivity of human small-cell lung carcinoma growing orthotopically compared to subcutaneously in SCID mice: the importance of orthotopic models to obtain relevant drug evaluation data.
Kuo TH; Kubota T; Watanabe M; Furukawa T; Kase S; Tanino H; Saikawa Y; Ishibiki K; Kitajima M; Hoffman RM
Anticancer Res; 1993; 13(3):627-30. PubMed ID: 8391244
[TBL] [Abstract][Full Text] [Related]
12. Marine sponge-derived polymeric alkylpyridinium salts as a novel tumor chemotherapeutic targeting the cholinergic system in lung tumors.
Paleari L; Trombino S; Falugi C; Gallus L; Carlone S; Angelini C; Sepcic K; Turk T; Faimali M; Noonan DM; Albini A
Int J Oncol; 2006 Dec; 29(6):1381-8. PubMed ID: 17088975
[TBL] [Abstract][Full Text] [Related]
13. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
Koshkina NV; Kleinerman ES; Waidrep C; Jia SF; Worth LL; Gilbert BE; Knight V
Clin Cancer Res; 2000 Jul; 6(7):2876-80. PubMed ID: 10914737
[TBL] [Abstract][Full Text] [Related]
14. Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy.
Kawakami M; Kawakami K; Stepensky VA; Maki RA; Robin H; Muller W; Husain SR; Puri RK
Clin Cancer Res; 2002 Nov; 8(11):3503-11. PubMed ID: 12429641
[TBL] [Abstract][Full Text] [Related]
15. The modifier subunit of glutamate cysteine ligase relates to cisplatin resistance in human small cell lung cancer xenografts in vivo.
Nishi M; Abe Y; Fujimori S; Hamamoto A; Inoue Y; Miyazaki N; Oida Y; Ikoma N; Ohnishi Y; Yamazaki H; Ueyama Y; Nakamura M
Oncol Rep; 2005 Aug; 14(2):421-4. PubMed ID: 16012725
[TBL] [Abstract][Full Text] [Related]
16. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
17. Pattern of antitumor activity of a novel camptothecin, ST1481, in a large panel of human tumor xenografts.
Pratesi G; De Cesare M; Carenini N; Perego P; Righetti SC; Cucco C; Merlini L; Pisano C; Penco S; Carminati P; Vesci L; Zunino F
Clin Cancer Res; 2002 Dec; 8(12):3904-9. PubMed ID: 12473606
[TBL] [Abstract][Full Text] [Related]
18. A dominated and resistant subpopulation causes regrowth after response to 1,3-bis(2-chloroethyl)-1-nitrosourea treatment of a heterogeneous small cell lung cancer xenograft in nude mice.
Aabo K; Roed H; Vindeløv LL; Spang-Thomsen M
Cancer Res; 1994 Jun; 54(12):3295-9. PubMed ID: 8205552
[TBL] [Abstract][Full Text] [Related]
19. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
[TBL] [Abstract][Full Text] [Related]
20. Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung tumor growth and improve survival.
Jin H; Yang R; Fong S; Totpal K; Lawrence D; Zheng Z; Ross J; Koeppen H; Schwall R; Ashkenazi A
Cancer Res; 2004 Jul; 64(14):4900-5. PubMed ID: 15256461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
